Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-09-14 OYLER JOHN Chief Executive Officer Sale −600 $247.01 $148K 19,139
2020-09-14 OYLER JOHN Chief Executive Officer Sale −1,500 $248.56 $373K 17,639
2020-09-14 OYLER JOHN Chief Executive Officer Sale −7,116 $249.73 $1.8M 10,523
2020-09-14 OYLER JOHN Chief Executive Officer Sale −6,877 $250.56 $1.7M 3,646
2020-09-14 OYLER JOHN Chief Executive Officer Sale −3,476 $251.90 $876K 170
2020-09-14 OYLER JOHN Chief Executive Officer Sale −170 $252.53 $43K 0
2020-09-14 Liang Howard CFO & Chief Strategy Officer Option exercise +14,000 $6.50 $91K 14,000
2020-09-14 Liang Howard CFO & Chief Strategy Officer Sale −400 $247.46 $99K 13,600
2020-09-14 Liang Howard CFO & Chief Strategy Officer Sale −1,681 $248.93 $418K 11,919
2020-09-14 Liang Howard CFO & Chief Strategy Officer Sale −6,478 $249.97 $1.6M 5,441
2020-09-14 Liang Howard CFO & Chief Strategy Officer Sale −3,157 $250.71 $791K 2,284
2020-09-14 Liang Howard CFO & Chief Strategy Officer Sale −2,181 $251.95 $550K 103
2020-09-14 Liang Howard CFO & Chief Strategy Officer Sale −103 $252.59 $26K 0
2020-09-14 Liang Howard CFO & Chief Strategy Officer Option exercise · Stock Option (Right to Buy) −182,000 3,613,000
2020-09-03 Huang Jane CMO, Hematology Sale −1,000 $232.25 $232K 2,128
2020-09-03 Huang Jane CMO, Hematology Sale −1,411 $232.94 $329K 717
2020-09-03 Huang Jane CMO, Hematology Sale −500 $234.17 $117K 217
2020-09-03 Huang Jane CMO, Hematology Sale −217 $235.21 $51K 0
2020-09-02 OYLER JOHN Chief Executive Officer Sale −1,200 $224.52 $269K 26,607
2020-09-02 OYLER JOHN Chief Executive Officer Sale −4,482 $226.07 $1.0M 22,125

Page 80 of 99 · 1,972 trades